← ANALYST RATINGS · TIPRANKS

Encompass Health (EHC): analyst forecast and price target

$128 +0.08% close 16.10.26 · market cap $12.3B · Healthcare · Medical - Care Facilities
Price targets and ratings of

Analyst consensus

Strong Buy

10 Buy0 Hold0 Sell

Ratings of 10 analysts in the last 3 months

12-month forecast

$147+14.8% upside

Based on 10 price targets given in the last 3 months, the average target is $147, the highest $155, the lowest $140. The average is +14.8% from the last price of $128.

$100$120$140Jan 26AprJulOctJan 27AprJulOctHigh$155Average$147Low$140
Highest target $155 Average target $147 Lowest target $140
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
A.J. Rice★★★★★★★★★★#690 · hits 61% · avg +9.8% UBS $155 Buy +21.2% Reiterated 12.10.26on TipRanks Oct 13 01:20 +0.9%next day −0.1%
Ryan Langston★★★★★★★★★★#9454 · hits 47% · avg −0.6% TD Cowen $140 Buy +9.5% Reiterated 02.10.26on TipRanks Oct 5 04:07 −0.1%next day +0.3% · 5 days +1.8%
Andrew Cooper★★★★★★★★★★#11107 · hits 40% · avg −3.0% Raymond James $150 Buy +17.3% Reiterated 28.09.26on TipRanks 09:25 +1.2%next day −0.2% · 5 days −3.5%
Pito Chickering★★★★★★★★★★#1500 · hits 61% · avg +9.8% Deutsche Bank $142 Buy +11.1% Reiterated 18.09.26on TipRanks Sep 21 04:45 −1.3%next day −1.7% · 5 days +0.1%
Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% KeyBanc $147 Buy +15.0% Reiterated 17.09.26on TipRanks 02:35 −1.8%next day −1.3% · 5 days −1.8%
David S Macdonald★★★★★★★★★★#400 · hits 63% · avg +13.2% Truist Financial $150 Buy +17.3% Reiterated 11.08.26on TipRanks Aug 12 22:25 0.0%next day −0.7% · 5 days −2.2%
Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% Mizuho Securities $140 Buy +9.5% Reiterated 11.08.26on TipRanks Aug 12 08:15 0.0%next day −0.7% · 5 days −2.2%
Joanna Gajuk★★★★★★★★★★#5858 · hits 54% · avg +1.2% Bank of America Securities $150 → $153+2.0% Buy +19.7% Reiterated 06.08.26on TipRanks 08:01 +12.7%next day −0.3% · 5 days −2.2%
Andrew Mok CFA★★★★★★★★★★#11840 · hits 51% · avg −4.8% Barclays $140 → $144+2.9% Buy +12.6% Reiterated 06.08.26on TipRanks 04:16 +12.7%next day −0.3% · 5 days −2.2%
Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% William Blair — Buy — Reiterated 05.08.26on TipRanks 18:25 +12.7%next day −0.3% · 5 days −2.2%
Unknown Analyst Stephens $140 Buy +9.5% Reiterated 04.05.26on TipRanks 07:35 −0.4%next day −2.2% · 5 days −4.7%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Encompass Health

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months Ann Hynes★★★★★★★★★★Mizuho Securities · #1003
Hits 59%296 of 500 Average return +8.1%
1 year Pito Chickering★★★★★★★★★★Deutsche Bank · #1500
Hits 61%130 of 214 Average return +9.8%
2 years Pito Chickering★★★★★★★★★★Deutsche Bank · #1500
Hits 61%130 of 214 Average return +9.8%

Most profitable

3 months Andrew Mok CFA★★★★★★★★★★Barclays · #11840
Hits 51%157 of 307 Average return −4.8%
1 year David S Macdonald★★★★★★★★★★Truist Financial · #400
Hits 63%312 of 499 Average return +13.2%
2 years Pito Chickering★★★★★★★★★★Deutsche Bank · #1500
Hits 61%130 of 214 Average return +9.8%

How the average price target moved

The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 05.10.26: target $147 at a price of $120 (+22.5%); now: $147 at $128 (+14.8%).

$120$130$140Sep 15Oct 1Oct 15Top analysts$147Average target$147Price$128

PriceAverage targetTop analysts’ target

Recommendation trend

05101516Oct 259Nov7Dec2Jan 2615Feb16Mar212Apr115May116Jun12Jul14Aug14Sep14Oct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy110000
Buy151612141414
Hold000000
Sell000000

Earnings and sales forecast

Next report: 28.10.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $1.36 (from $1.25 to $1.41). Last quarter: $1.55.

Sales

Next quarter’s sales estimate — $1.6B (from $1.6B to $1.6B). Last quarter: $1.6B.

Best top-analyst consensus in the sector · Healthcare

AXGNAxoGen
MDWDMediwound
OCULOcular Therapeutix
OVIDOvid Therapeutics
ZYMEZymeworks
About Encompass Health

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Data from the stock’s TipRanks forecast page, read 52 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗